HOME ＞ 研究業績詳細
研究業績詳細
石川 大（イシカワ ダイ）
| 研究テーマ | IBDの治療、免疫異常、腸内細菌療法 |
|---|---|
| 研究業績（論文） | K Nomura, D Ishikawa, et al. Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis. J Clin Med. 2021 April 17;10:1749. Koki Okahara, Dai Ishikawa,et al. Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. Received: 28 April 2020; Accepted: 28 May 2020; Published: 31 May 2020 Takahashi M, Ishikawa D, et al. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol. 2019 Mar;126(3):973-984. Ishikawa D, et al. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy with Fecal Microbiota Transplantation and Antibiotics Inflamm Bowel Dis. 2018 Aug ;29;24(12):2590-2598 石川 大「総説：便移植の現状と展望」腸内細菌学雑誌2018 Jul 32:137-144 Ishikawa D. Fecal Microbiota Transplantation for the Treatment of Gastrointestinal Disease: Present and Future Prospects Gastroenterological Endoscopy. 2018 Apr ;60(4):969-980 Ishikawa D, et al. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis. Inflamm Bowel Dis. 2017 Jan ;23(1):116-125. Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease. Ishikawa D, et al. Mucosal Immunol. 2012 Jul 11. doi: 10.1038/mi.2012.67. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. Corridoni D, Ishikawa D, et al. PLoS One. 2012;7(7):e42067. Epub 2012 Jul 25 |
| 研究者 | 教育活動 | ホームページURL |